table of content
1 Study Coverage
1.1 Influenza Drugs Product Introduction
1.2 Global Influenza Drugs Outlook 2017 VS 2022 VS 2028
1.2.1 Global Influenza Drugs Sales in US$ Million for the Year 2017-2028
1.2.2 Global Influenza Drugs Sales in Volume for the Year 2017-2028
1.3 United States Influenza Drugs Outlook 2017 VS 2022 VS 2028
1.3.1 United States Influenza Drugs Sales in US$ Million for the Year 2017-2028
1.3.2 United States Influenza Drugs Sales in Volume for the Year 2017-2028
1.4 Influenza Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Influenza Drugs in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Influenza Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Influenza Drugs Market Dynamics
1.5.1 Influenza Drugs Industry Trends
1.5.2 Influenza Drugs Market Drivers
1.5.3 Influenza Drugs Market Challenges
1.5.4 Influenza Drugs Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Influenza Drugs Market Segment by Type
2.1.1 Zanamivir
2.1.2 Oseltamivir Phosphate
2.1.3 Peramivir
2.1.4 Other Influenza Drugs
2.2 Global Influenza Drugs Market Size by Type
2.2.1 Global Influenza Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Influenza Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Influenza Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Influenza Drugs Market Size by Type
2.3.1 United States Influenza Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Influenza Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Influenza Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Influenza Drugs Market Segment by Application
3.1.1 Adults
3.1.2 Chidren
3.2 Global Influenza Drugs Market Size by Application
3.2.1 Global Influenza Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Influenza Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Influenza Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Influenza Drugs Market Size by Application
3.3.1 United States Influenza Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Influenza Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Influenza Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Influenza Drugs Competitor Landscape by Company
4.1 Global Influenza Drugs Market Size by Company
4.1.1 Top Global Influenza Drugs Manufacturers Ranked by Revenue (2021)
4.1.2 Global Influenza Drugs Revenue by Manufacturer (2017-2022)
4.1.3 Global Influenza Drugs Sales by Manufacturer (2017-2022)
4.1.4 Global Influenza Drugs Price by Manufacturer (2017-2022)
4.2 Global Influenza Drugs Concentration Ratio (CR)
4.2.1 Influenza Drugs Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Influenza Drugs in 2021
4.2.3 Global Influenza Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Influenza Drugs Manufacturing Base Distribution, Product Type
4.3.1 Global Influenza Drugs Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Influenza Drugs Product Type
4.3.3 Date of International Manufacturers Enter into Influenza Drugs Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Influenza Drugs Market Size by Company
4.5.1 Top Influenza Drugs Players in United States, Ranked by Revenue (2021)
4.5.2 United States Influenza Drugs Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Influenza Drugs Sales by Players (2020, 2021 & 2022)
5 Global Influenza Drugs Market Size by Region
5.1 Global Influenza Drugs Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Influenza Drugs Market Size in Volume by Region (2017-2028)
5.2.1 Global Influenza Drugs Sales in Volume by Region: 2017-2022
5.2.2 Global Influenza Drugs Sales in Volume Forecast by Region (2023-2028)
5.3 Global Influenza Drugs Market Size in Value by Region (2017-2028)
5.3.1 Global Influenza Drugs Sales in Value by Region: 2017-2022
5.3.2 Global Influenza Drugs Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Influenza Drugs Market Size YoY Growth 2017-2028
6.1.2 North America Influenza Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Influenza Drugs Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Influenza Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Influenza Drugs Market Size YoY Growth 2017-2028
6.3.2 Europe Influenza Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Influenza Drugs Market Size YoY Growth 2017-2028
6.4.2 Latin America Influenza Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Influenza Drugs Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Influenza Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Bristol-Myers Squibb]
7.1.1 Bristol-Myers Squibb] Corporation Information
7.1.2 Bristol-Myers Squibb] Description and Business Overview
7.1.3 Bristol-Myers Squibb] Influenza Drugs Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Bristol-Myers Squibb] Influenza Drugs Products Offered
7.1.5 Bristol-Myers Squibb] Recent Development
7.2 AstraZeneca
7.2.1 AstraZeneca Corporation Information
7.2.2 AstraZeneca Description and Business Overview
7.2.3 AstraZeneca Influenza Drugs Sales, Revenue and Gross Margin (2017-2022)
7.2.4 AstraZeneca Influenza Drugs Products Offered
7.2.5 AstraZeneca Recent Development
7.3 Eli Lilly
7.3.1 Eli Lilly Corporation Information
7.3.2 Eli Lilly Description and Business Overview
7.3.3 Eli Lilly Influenza Drugs Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Eli Lilly Influenza Drugs Products Offered
7.3.5 Eli Lilly Recent Development
7.4 Roche
7.4.1 Roche Corporation Information
7.4.2 Roche Description and Business Overview
7.4.3 Roche Influenza Drugs Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Roche Influenza Drugs Products Offered
7.4.5 Roche Recent Development
7.5 GlaxoSmithKline
7.5.1 GlaxoSmithKline Corporation Information
7.5.2 GlaxoSmithKline Description and Business Overview
7.5.3 GlaxoSmithKline Influenza Drugs Sales, Revenue and Gross Margin (2017-2022)
7.5.4 GlaxoSmithKline Influenza Drugs Products Offered
7.5.5 GlaxoSmithKline Recent Development
7.6 Novartis
7.6.1 Novartis Corporation Information
7.6.2 Novartis Description and Business Overview
7.6.3 Novartis Influenza Drugs Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Novartis Influenza Drugs Products Offered
7.6.5 Novartis Recent Development
7.7 Pfizer
7.7.1 Pfizer Corporation Information
7.7.2 Pfizer Description and Business Overview
7.7.3 Pfizer Influenza Drugs Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Pfizer Influenza Drugs Products Offered
7.7.5 Pfizer Recent Development
7.8 Sanofi Pasteur
7.8.1 Sanofi Pasteur Corporation Information
7.8.2 Sanofi Pasteur Description and Business Overview
7.8.3 Sanofi Pasteur Influenza Drugs Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Sanofi Pasteur Influenza Drugs Products Offered
7.8.5 Sanofi Pasteur Recent Development
7.9 Bayer
7.9.1 Bayer Corporation Information
7.9.2 Bayer Description and Business Overview
7.9.3 Bayer Influenza Drugs Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Bayer Influenza Drugs Products Offered
7.9.5 Bayer Recent Development
7.10 Celgene
7.10.1 Celgene Corporation Information
7.10.2 Celgene Description and Business Overview
7.10.3 Celgene Influenza Drugs Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Celgene Influenza Drugs Products Offered
7.10.5 Celgene Recent Development
7.11 Seqirus
7.11.1 Seqirus Corporation Information
7.11.2 Seqirus Description and Business Overview
7.11.3 Seqirus Influenza Drugs Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Seqirus Influenza Drugs Products Offered
7.11.5 Seqirus Recent Development
7.12 Protein Sciences Corporation
7.12.1 Protein Sciences Corporation Corporation Information
7.12.2 Protein Sciences Corporation Description and Business Overview
7.12.3 Protein Sciences Corporation Influenza Drugs Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Protein Sciences Corporation Products Offered
7.12.5 Protein Sciences Corporation Recent Development
7.13 Serum Institute of India
7.13.1 Serum Institute of India Corporation Information
7.13.2 Serum Institute of India Description and Business Overview
7.13.3 Serum Institute of India Influenza Drugs Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Serum Institute of India Products Offered
7.13.5 Serum Institute of India Recent Development
7.14 Emergent Biosolutions
7.14.1 Emergent Biosolutions Corporation Information
7.14.2 Emergent Biosolutions Description and Business Overview
7.14.3 Emergent Biosolutions Influenza Drugs Sales, Revenue and Gross Margin (2017-2022)
7.14.4 Emergent Biosolutions Products Offered
7.14.5 Emergent Biosolutions Recent Development
7.15 BioCryst Pharmaceuticals
7.15.1 BioCryst Pharmaceuticals Corporation Information
7.15.2 BioCryst Pharmaceuticals Description and Business Overview
7.15.3 BioCryst Pharmaceuticals Influenza Drugs Sales, Revenue and Gross Margin (2017-2022)
7.15.4 BioCryst Pharmaceuticals Products Offered
7.15.5 BioCryst Pharmaceuticals Recent Development
7.16 Alvogen
7.16.1 Alvogen Corporation Information
7.16.2 Alvogen Description and Business Overview
7.16.3 Alvogen Influenza Drugs Sales, Revenue and Gross Margin (2017-2022)
7.16.4 Alvogen Products Offered
7.16.5 Alvogen Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Influenza Drugs Industry Chain Analysis
8.2 Influenza Drugs Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Influenza Drugs Distributors
8.3 Influenza Drugs Production Mode & Process
8.4 Influenza Drugs Sales and Marketing
8.4.1 Influenza Drugs Sales Channels
8.4.2 Influenza Drugs Distributors
8.5 Influenza Drugs Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
